Bl 48 - analogs
| Prices in pharmacies: Instructions Bl 48 | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . Loratadine ✘ (incl) Josamycin ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 49% Kid 21 neutral
- 44% St 25 neutral
- 39% Ren 11 neutral
- 38% Sp 17 neutral
- 37% Ren 9 neutral
- 35% Ren 5 neutral
- 34% Gb 25 neutral
- 34% Ren 14 neutral
- 33% Gb 24 neutral
- 32% Kid 20 neutral
- 31% Ren 8 neutral
- 30% Sp 9 neutral
- 29% Gb 34 neutral
- 29% St 22 neutral
- 29% Ren 13 neutral
- 28% Bl 20 neutral
- 28% Bl 22 neutral
- 27% Sp 2 neutral
- 26% Sp 5 neutral
- 26% PC20 Цзинь-цзинь, юй-е neutral
- 26% Bl 49 neutral
- 26% Du 9 neutral
- 25% Bl 47 neutral
- 24% Ren 3 neutral
- 24% Kid 14 neutral
- 24% Kid 10 neutral
- 23% Gb 37 neutral
- 23% Bl 29 neutral
- 22% Sp 1 neutral
- 22% St 19 neutral
- 21% Bl 25 neutral
- 21% St 41 neutral
- 21% P 3 neutral
- 21% St 23 neutral
- 20% Sp 8 neutral
- 20% St 37 neutral
- 20% Ren 10 neutral
- 20% Bl 19 neutral
- 19% Liv 13 neutral
- 18% Sp 6 neutral
- 18% Ren 17 neutral
- 17% Sp 3 neutral
- 17% Bl 40 neutral
- 17% L.i. 7 neutral
- 17% St 9 neutral
- 17% P 5 neutral
- 17% Bl 21 neutral
- 16% Gb 41 neutral
- 16% Ren 12 neutral
- 16% Ren 4 neutral
Learn more about the selection of analogues
- The drug has «Bl 48» no complete analogues; 51 analog by action, the most similar - Kid 21 .
- Medical online service has selected the best substitutes for Bl 48 based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Bl 48 to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.